ZA969521B - Sulfonylamino-substituted benzoylguanidines a process for their preparation their use as medicament or diagnostic aid and medicament containing them - Google Patents
Sulfonylamino-substituted benzoylguanidines a process for their preparation their use as medicament or diagnostic aid and medicament containing themInfo
- Publication number
- ZA969521B ZA969521B ZA969521A ZA969521A ZA969521B ZA 969521 B ZA969521 B ZA 969521B ZA 969521 A ZA969521 A ZA 969521A ZA 969521 A ZA969521 A ZA 969521A ZA 969521 B ZA969521 B ZA 969521B
- Authority
- ZA
- South Africa
- Prior art keywords
- medicament
- sulfonylamino
- preparation
- diagnostic aid
- substituted benzoylguanidines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
- C07C303/40—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Pulmonology (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19542306A DE19542306A1 (de) | 1995-11-14 | 1995-11-14 | Sulfonylamino-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA969521B true ZA969521B (en) | 1997-05-14 |
Family
ID=7777358
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA969521A ZA969521B (en) | 1995-11-14 | 1996-11-13 | Sulfonylamino-substituted benzoylguanidines a process for their preparation their use as medicament or diagnostic aid and medicament containing them |
Country Status (23)
Country | Link |
---|---|
US (1) | US5856344A (no) |
EP (1) | EP0774459A1 (no) |
JP (1) | JPH09169721A (no) |
KR (1) | KR970026597A (no) |
CN (1) | CN1159444A (no) |
AR (1) | AR004318A1 (no) |
AU (1) | AU706231B2 (no) |
BR (1) | BR9605568A (no) |
CA (1) | CA2190220A1 (no) |
CZ (1) | CZ332596A3 (no) |
DE (1) | DE19542306A1 (no) |
HR (1) | HRP960534A2 (no) |
HU (1) | HUP9603150A3 (no) |
ID (1) | ID17177A (no) |
IL (1) | IL119606A0 (no) |
MX (1) | MX9605538A (no) |
NO (1) | NO964812L (no) |
NZ (1) | NZ299739A (no) |
PL (1) | PL316441A1 (no) |
SK (1) | SK146596A3 (no) |
TR (1) | TR199600892A2 (no) |
TW (1) | TW400320B (no) |
ZA (1) | ZA969521B (no) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19737463A1 (de) * | 1997-08-28 | 1999-03-04 | Hoechst Marion Roussel De Gmbh | Verwendung von Inhibitoren des Natrium-Wasserstoff-Austauschers zur Herstellung eines Arzneimittels zur Behandlung von Erkrankungen, die durch Protozoen verursacht werden |
DE19859727A1 (de) | 1998-12-23 | 2000-06-29 | Aventis Pharma Gmbh | Die Verwendung von Hemmern des Natrium-Wasserstoff-Austauschers zur Herstellung eines Medikaments zur Verhinderung von altersbedingten Organ-Dysfunktionen, altersbedingten Erkrankungen zur Lebensverlängerung |
TW200614995A (en) * | 2004-11-10 | 2006-05-16 | Nicholas Piramal India Ltd | Tricyclic guanidine derivatives as sodium-proton exchange inhibitors |
CN102675163B (zh) * | 2012-05-23 | 2014-10-29 | 湘潭大学 | 一种磺酰胺的制备方法 |
CN103553860B (zh) * | 2013-11-03 | 2015-07-15 | 天津市亨必达化学合成物有限公司 | 一种磺酰胺类化合物的合成方法 |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3780027A (en) * | 1970-04-29 | 1973-12-18 | Merck & Co Inc | Anthranilic acid derivatives |
US5185364A (en) * | 1988-01-15 | 1993-02-09 | Abbott Laboratories | Aminomethyl-chroman and -thiochroman compounds |
US5140039A (en) * | 1988-01-15 | 1992-08-18 | Abbott Laboratories | Aminomethyl-thiochroman compounds |
JP2673024B2 (ja) * | 1988-01-15 | 1997-11-05 | アボツト・ラボラトリーズ | アミノメチル‐クロマン及び‐チオクロマン化合物 |
DE3929582A1 (de) * | 1989-09-06 | 1991-03-07 | Hoechst Ag | Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament |
DE59302959D1 (de) * | 1992-02-15 | 1996-07-25 | Hoechst Ag | 3,5-Substituierte Benzoylguanidine, mit antiarrythmischer Wirkung und inhibierender Wirkung auf die Proliferationen von Zellen |
ATE158278T1 (de) * | 1992-02-15 | 1997-10-15 | Hoechst Ag | Ortho-substituierte benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament oder diagnostikum sowie sie enthaltendes medikament |
CZ284456B6 (cs) * | 1992-02-15 | 1998-12-16 | Hoechst Aktiengesellschaft | Aminosubstituované benzoylguanidiny, způsob jejich přípravy, jejich použití jako léčiv a léčivo, které je obsahuje |
DE59304166D1 (de) * | 1992-07-01 | 1996-11-21 | Hoechst Ag | 3,4,5-Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
ATE147375T1 (de) * | 1992-09-22 | 1997-01-15 | Hoechst Ag | Benzoylguanidine, verfahren zu ihrer herstellung, sowie ihre verwendung als antiarrhythmika |
DE69329787T2 (de) * | 1992-09-28 | 2001-06-13 | Hoechst Ag | Antiarrhythmische und cardioprotektive substituierte 1(2H)-Isochinoline, Verfahren zu deren Herstellung, diese enthaltende Arzneimittel und ihre Anwendung für die Herstellung eines Arzneimittels zur Behandlung von Herzinsuffizienzen |
EP0600371B1 (de) * | 1992-12-02 | 1999-02-03 | Hoechst Aktiengesellschaft | Guanidinalkyl-1, 1-bisphosphonsäurederivate, Verfahren zu ihrer Herstellung und ihre Verwendung |
TW250479B (no) * | 1992-12-15 | 1995-07-01 | Hoechst Ag | |
TW250477B (no) * | 1992-12-15 | 1995-07-01 | Hoechst Ag | |
DK0603650T3 (da) * | 1992-12-16 | 1997-10-20 | Hoechst Ag | 3,5-Substituerede aminobenzoylguanidiner, fremgangsmåde til deres freemstilling, deres anvendelse som lægemiddel eller diagnostikum samt lægemiddel med indhold deraf. |
EP0604852A1 (de) * | 1992-12-28 | 1994-07-06 | Hoechst Aktiengesellschaft | 2,4-Substituierte 5-(N-substituierte-Sulfamoyl)-Benzoylguanidine, als Antiarrythmika, Inhibitoren der Proliferationen von Zellen, und Inhibitoren des Natrium-Protonen-Antiporters |
DK0612723T3 (da) * | 1993-02-20 | 1998-03-30 | Hoechst Ag | Substituerede benzoylguanidiner, fremgangsmåde til fremstilling, deres anvendelse som lægemiddel, som inhibitor af den cellulære Na+/H+-udbytning eller som diagnostikum samt lægemiddel med indhold deraf |
EP0612724B1 (de) * | 1993-02-23 | 1996-12-27 | Hoechst Aktiengesellschaft | Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe- Verfahren zu ihrer Herstellung und ihre Verwendung als Pharmazeutika |
IL109570A0 (en) * | 1993-05-17 | 1994-08-26 | Fujisawa Pharmaceutical Co | Guanidine derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof |
DE4318658A1 (de) * | 1993-06-04 | 1994-12-08 | Hoechst Ag | Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE4318756A1 (de) * | 1993-06-05 | 1994-12-08 | Hoechst Ag | Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE4325822A1 (de) * | 1993-07-31 | 1995-02-02 | Hoechst Ag | Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
EP0639573A1 (de) * | 1993-08-03 | 1995-02-22 | Hoechst Aktiengesellschaft | Benzokondensierte 5-Ringheterocyclen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, ihre Verwendung als Diagnostikum, sowie sie enthaltendes Medikament |
DE4327244A1 (de) * | 1993-08-13 | 1995-02-16 | Hoechst Ag | Harnstoffsubstituierte Benzoylguandine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE4328869A1 (de) * | 1993-08-27 | 1995-03-02 | Hoechst Ag | Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE4344550A1 (de) * | 1993-12-24 | 1995-06-29 | Hoechst Ag | Substituierte 1-Oxo-1,2-dihydro-isochinolinoyl- und 1,1-Dioxo-2H-1,2-benzothiazinoylguanidine, Verfahrenzu ihrer Herstellung, ihre Verwendung als Medikamentt oder Diagnostikum sowie sie enthaltendes Medikamen |
TW415937B (en) * | 1994-01-25 | 2000-12-21 | Hoechst Ag | Phenyl-substituted alkylcarboxylic acid guanidides bearing perfluoroalkyl groups, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
DE4412334A1 (de) * | 1994-04-11 | 1995-10-19 | Hoechst Ag | Substituierte N-Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE4415873A1 (de) * | 1994-05-05 | 1995-11-09 | Hoechst Ag | Substituierte bizyklische Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE4417004A1 (de) * | 1994-05-13 | 1995-11-16 | Hoechst Ag | Perfluoralkyl-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE4422685A1 (de) * | 1994-06-29 | 1996-01-04 | Hoechst Ag | Ortho-amino-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
IL114670A0 (en) * | 1994-08-05 | 1995-11-27 | Fujisawa Pharmaceutical Co | Guanidine derivatives pharmaceutical compositions containing the same and processes for the preparation thereof |
DE4432101A1 (de) * | 1994-09-09 | 1996-03-14 | Hoechst Ag | Aminosäure-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE4432106A1 (de) * | 1994-09-09 | 1996-03-14 | Hoechst Ag | Mit Heterocyclen-N-Oxid-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum, sie enthaltendes Medikament sowie Zwischenprodukte zu ihrer Herstellung |
DE4432105A1 (de) * | 1994-09-09 | 1996-03-14 | Hoechst Ag | Fluoro-alkyl/alkenyl-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE4441880A1 (de) * | 1994-11-24 | 1996-05-30 | Hoechst Ag | Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DK0723956T3 (da) * | 1995-01-30 | 2000-04-17 | Hoechst Ag | Basisk substituerede benzoylguanidiner, fremgangsmåde til fremstilling deraf, anvendelse deraf som lægemiddel eller diagnos |
-
1995
- 1995-11-14 DE DE19542306A patent/DE19542306A1/de not_active Withdrawn
-
1996
- 1996-10-08 PL PL96316441A patent/PL316441A1/xx unknown
- 1996-10-31 US US08/741,588 patent/US5856344A/en not_active Expired - Fee Related
- 1996-11-04 EP EP96117606A patent/EP0774459A1/de not_active Withdrawn
- 1996-11-12 AU AU71733/96A patent/AU706231B2/en not_active Ceased
- 1996-11-12 NZ NZ299739A patent/NZ299739A/xx unknown
- 1996-11-12 SK SK1465-96A patent/SK146596A3/sk unknown
- 1996-11-12 TR TR96/00892A patent/TR199600892A2/xx unknown
- 1996-11-12 CZ CZ963325A patent/CZ332596A3/cs unknown
- 1996-11-12 CN CN96121311A patent/CN1159444A/zh active Pending
- 1996-11-12 IL IL11960696A patent/IL119606A0/xx unknown
- 1996-11-13 KR KR1019960053571A patent/KR970026597A/ko not_active Application Discontinuation
- 1996-11-13 TW TW085113944A patent/TW400320B/zh active
- 1996-11-13 JP JP8301378A patent/JPH09169721A/ja active Pending
- 1996-11-13 HR HR19542306.2A patent/HRP960534A2/hr not_active Application Discontinuation
- 1996-11-13 ZA ZA969521A patent/ZA969521B/xx unknown
- 1996-11-13 CA CA002190220A patent/CA2190220A1/en not_active Abandoned
- 1996-11-13 MX MX9605538A patent/MX9605538A/es unknown
- 1996-11-13 NO NO964812A patent/NO964812L/no unknown
- 1996-11-14 BR BR9605568A patent/BR9605568A/pt unknown
- 1996-11-14 ID IDP963325A patent/ID17177A/id unknown
- 1996-11-14 HU HU9603150A patent/HUP9603150A3/hu unknown
- 1996-12-11 AR ARP960105144A patent/AR004318A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
DE19542306A1 (de) | 1997-05-15 |
ID17177A (id) | 1997-12-04 |
SK146596A3 (en) | 1997-11-05 |
CA2190220A1 (en) | 1997-05-15 |
CZ332596A3 (cs) | 1998-05-13 |
CN1159444A (zh) | 1997-09-17 |
NO964812L (no) | 1997-05-15 |
HUP9603150A2 (hu) | 1998-01-28 |
TW400320B (en) | 2000-08-01 |
NO964812D0 (no) | 1996-11-13 |
HUP9603150A3 (en) | 1998-12-28 |
BR9605568A (pt) | 1998-08-18 |
TR199600892A2 (tr) | 1997-06-21 |
HRP960534A2 (en) | 1998-02-28 |
AR004318A1 (es) | 1998-11-04 |
US5856344A (en) | 1999-01-05 |
AU706231B2 (en) | 1999-06-10 |
HU9603150D0 (en) | 1997-01-28 |
MX9605538A (es) | 1997-05-31 |
KR970026597A (ko) | 1997-06-24 |
IL119606A0 (en) | 1997-02-18 |
NZ299739A (en) | 1997-09-22 |
JPH09169721A (ja) | 1997-06-30 |
AU7173396A (en) | 1997-05-22 |
EP0774459A1 (de) | 1997-05-21 |
PL316441A1 (en) | 1997-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA969211B (en) | Substituted sulfonimidamides processes for their preparation their use as a medicament or diagnostic and medicament comprising them | |
IL118327A0 (en) | Fluorophenyl-substituted alkenylcarboxylic acid guanidides process for their preparation their use as a medicament or diagnostic and medicament containing them | |
IL116940A0 (en) | Basically-substituted benzoylguanidines a process for preparing them their use as a medicament or diagnostic agent and a medicament containing them | |
IL118278A0 (en) | Substituted benzyloxycarbonyl-guanidines process for their preparation their use as a medicament or diagnostic and medicament containing them | |
IL118925A0 (en) | Substituted cinnamic acid guanidides a process for their preparation their use as medicaments or diagnostic agents and medicaments comprising them | |
IL119293A0 (en) | Substituted benzoylguanidines a process for their preparation their use as medicament or diagnostic agent and medicament comprising them | |
ZA961231B (en) | Substituted benzenesulfonyllureas and -thioureas process for their preparation their use as a medicament or diagnostic and medicament containing them | |
IL120924A0 (en) | Substituted 2-naphthoylguanidines process for their preparation their use as a medicament or diagnostic and medicaments containing them | |
ZA955342B (en) | Ortho-amino-substituted benzoylguanidines a process for their preparation their use as a medicament or diagnostic agent and also a medicament containing them | |
IL118887A0 (en) | 4-fluoroalkyl-substituted benzoylguanidines process for their preparation their use as a medicament or diagnostic and medicament containing them | |
AU2465097A (en) | Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them | |
ZA959972B (en) | Substituted benzoylguanidines process for their preparation their use as a medicament or diagnostic and medicament containing them | |
ZA969521B (en) | Sulfonylamino-substituted benzoylguanidines a process for their preparation their use as medicament or diagnostic aid and medicament containing them | |
IL120925A0 (en) | Substituted 1-naphthoylguanidines process for their preparation their use as a medicament or diagnostic and medicaments containing them | |
IL120214A0 (en) | Substituted thiophenylalkenylcarboxylic acid guanidides process for their preparation their use as a medicament or diagnostic and medicament containing them | |
IL121085A0 (en) | Ortho-substituted benzoylguanidines process for their preparation their use as a medicament or diagnostic and medicaments comprising them | |
IL116980A0 (en) | Substituted thiophenylsulfonylureas and -thioureas processes for their preparation their use as a medicament or diagnostic and medicament containing them | |
IL120259A0 (en) | Ortho-substituted benzoylguanidines process for their preparation their use as a medicament or diagnostic and medicament containing them | |
IL120908A0 (en) | Bis-ortho-substituted benzoylguanidines processes for their preparation their use as a medicament or diagnostic and medicaments comprising them | |
ZA96644B (en) | Basically-substituted benzolyguanidines a process for preparing them their use as a medicament or diagnostic agent and medicament containing them | |
IL120093A0 (en) | Substituted diaryldicarboxylic acid diguanidides processes for their preparation their use as a medicament or diagnostic and medicament containing them | |
ZA982688B (en) | Ortho-substituted benzoylguanidines process for their preparation their use as a medicament or diagnostic and medicament comprising them | |
IL120358A0 (en) | Ortho-substituted benzoylguanidines process for their preparation their use as a medicament or diagnostic and medicaments comprising them | |
IL119637A0 (en) | Substituted benzenedicarboxylic acid diguanides process for their preparation their use as a medicament or diagnostic and medicaments containing them | |
IL120359A0 (en) | Ortho-substituted benzoylguanidines process for their preparation their use as a medicament or diagnostic and medicaments comprising them |